Detection of the viable myocardium. A perfusion scintigraphic study, before and after coronary bypass surgery in myocardial infarction patients;Deteccao do miocardio viavel. Estudo de perfusao, antes e apos a cirurgia de revascularizacao em portadores de infarto do miocardio

Arquivos Brasileiros de Cardiologia

Volumn 72, Issue 5, 1999, Pages 535-545

  Chalela, Willliam A ^a   Moffa, Paulo J ^b   Ramires, José A F ^b   Moraes, Aguinaldo P ^b   Soares Jr , José ^b   Meneghetti, José C ^b  

^a Servico de Radioisotopos   (Brazil)

^b NONE

Author keywords

Coronary artery disease; Myocardial perfusion scintigraphy; Myocardial viability

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; DIAGNOSTIC AGENT; THALLIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS SURGERY; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MALE; Q WAVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; HEART; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PREDICTION AND FORECASTING; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032879606     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X1999000500001     Document Type: Article

References (38)

1. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-6.
2. Primo G, Le Clerc JL, Goldstein JP, De Smet JM, Joris MP. Cardiac transplantation for the treatment of end-stage ischemic cardiomyopathy. Adv Cardiol 1988;36: 293-7.
3. Kriett JM, Kaye MP. The registry of the international society for heart transplantation: seventh official report ñ 1990. J Heart Transplant 1990;9:323-30.
4. Iskandrian AS, Shelbert HR. Myocardial viability assessment. J Nucl Med 1994a ; 35(suppl): 1S-3S.
5. Lucas JR, Botvinick EH, Dae MW. Myocardial viability: evidence provided by analysis of left ventricular systolic function. Coron Artery Dis 1993;4:485-94.
6. New York Heart Association: the criteria committee. Inc: Diseases of the heart and blood vessels. Nomenclature and criteria for 6th ed. Boston Little Brown, 1964.
7. Braunwald E. Heart Disease. A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia: WR Saunders Co, 1996.
8. Tranchesi J. Eletorcardiograma Normal e PatolÛgica. NoÁies de Vectorcardiografia. 6a ed. São Paulo: Editora Athenas, 1983:724.
9. Arie S. Circulação colateral com fator de proteção do miocárdio em portadores de insuficiência coronária crônica (Master thesis). São Paulo: Faculdade de Medicina da Universidade de São Paulo, 1977:53.
10. Dodge HT, Sandler H, Bellew BW, Lord Jr JD, Seatle W. The use of biplane angiography for the measurement of left ventricular volume in man. Am Heart J 1960;60:762.
11. Kennedy JW, Baxley WA, Figley MN. Quantitative angiography. The normal left ventricle in man. Circulation 1966;34:272.
12. Consenso Nacional de Ergometria. Florianópolis, SC. Arq Bras Cardiol 1995; 65:189-211.
13. rd ed. Philadelphia: Daves Company, 1986:526.
14. nd ed. Boston: PWS Publishers, 1986:584.
15. Fleiss JL. Statistical Methods for Rates and Proportions. New York: John Wiley & Sons, 1981:325.
16. th ed. vol.2, Cary, NC: SAS Institute. 1989:1686.
17. Hochberg MS, Parsonnet V, Gielschinsky I, Hussain SM. Newark NJ. Coronary artery bypass grafting in patients with ejection fractions below forty percent. J Thorac Cardiovasc Surg 1983; 86: 519-27.
18. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circulation 1983; 68: 939-50.
19. Dilsizan V, Rocco T, Freedman N, Martins BL, Bonow RO. Enhanced direction of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-6.
20. Tamaki N, Ohtani H, Yamashita K, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991; 32: 673-8.
21. Hendel RC. Single photon perfusion imaging for the assessment of myocardial viability, J Nucl Med 1994; 35: 235-315.
22. Strauss HW, Harrison K, Langan JK, Lebowitz E. Pitt B. Thallium 201 for myocardial imaging: relation to thallium-201 to regional myocardial perfusion. Circulation 1975; 51: 641-5.
23. Weich HF, Strauss W, Pitt B. The extraction of thallium-201 by the myocardium. Circulation 1977; 56: 188-97.
24. Pohost GM, Alpert NM, Ingwall JS, Strauss W. Thallium-201 redistribution: mechanism and clinical utility. Semin Nucl Med 1980; 10: 70-93.
25. Camici P, Arauno LI, Spinks T, et al. Increase uptake of 18F-fluorodeoxyglucose in post-ischemie myocardium in patients with exercise induced angina. Circulation 1986; 74: 81-6.
26. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjeotion and technetium-99m methoxyisobutyl. J Nucl Med 1992; 33: 505-11.
27. Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease: comparison of Tc-99m MIBI with Thallium reinjection and F-18 fluorodeoxyglucose. Circulation 1994; 89: 578-87.
28. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m hexakis-2 methoxy-2-methypropyl-isonitrile. Circulation 1988; 77: 491-8.
29. Sinusas AJ, Watson DD, Cannon JM, Jr ME, Beller GA. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol 1989; 14: 1785-93.
30. Gropler RJ, Bergmann SR-Myocardial viability ñ what is the definition? J Nucl Med 1991; 32: 10-2.
31. Bonow RO, D Isizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with coronary artery disease and left ventricular dysfunction: comparison of thallium scintigraphy with reinjecton and PET imaging with 18F-fluorodeoxyglucose. Circulation 1991;83:26-37.
32. Tillisch J, Brunken R, Marshall R. et al. Reversibility of cardiac wall-motion abnormalities predicted by position tomography. N Engl J Med 1986;314:884-8.
33. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M. Position emission. Position emission tomography using fluorine-18-deoxglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860-5.
34. Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990; 66: 394-9.
35. Fleming RM, Kiekeeide RL, Gould KL. Patterns in visual interpretation of coronary arteriograms as detected by quantitative coronary angiography. J. Am Coll Cardiol 1991; 18: 945-51.
36. Rodrigues AS, Santaera O, Fernandez M, et al. ñ Digital coronaryangiography: a new approach in the analysis of atherosclerotic plaque. Medicine 1991; 51: 209-16.
37. Meyer Sl, Dousk GCM, Twieg DB ñ Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol 1976; 38: 103-8.
38. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984; 310: 819-24